WEST CHESTER, Ohio–(HSMN NewsFeed)–AtriCure, Inc. (Nasdaq: ATRC ), a pharmaceutical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to completion and approval of a written sett…
Devices, Cardiology, Litigation
AtriCure, cardiac ablation, atrial fibrillation

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “AtriCure Announces Tentative Settlement with the Department of Justice”
Leave a Comment